Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rachel Ghiraldi
Institution:
Syndax Pharmaceuticals (United States)
Observed institution:
Syndax Pharmaceuticals (United States)
OpenAlex ID:
A5092807223
P561: Revumenib in Patients With Acute Leukemias: Compassionate Use Program Experience
2023
·
Jeffrey Rubnitz
, Ghayas C. Issa
, et al.
·
HemaSphere
Show more works
View as search
Works count:
1
Citation count:
H-index:
I10-index:
Year
Topic
Type